DHX Media announces the launch of three dedicated paid YouTube family entertainment channels. DHX Media expands its digital footprint with the launch of DHX Kids, DHX Junior and DHX Retro, and joins an elite group of premier content partners selected to be part of Google-owned YouTube’s first paid channels. DHX Media digital channels will be offered in multiple countries, including Australia (dhxkids.com.au, dhxjunior.com.au, dhxretro.com.au); Brazil (dhxkids.com.br, dhxjunior.com.br, dhxretro.com.br); Canada (dhxkids.ca, dhxjunior.ca, dhxencore.ca); France (dhxkids.fr, dhxjunior.fr, dhxretro.fr); Japan (dhxkids.jp); Korea (dhxkids.co.kr); Spain (dhxkids.es, dhxjunior.es, dhxretro.es); Russia (dhxkids.ru); the U.K. (dhxkids.co.uk, dhxjunior.co.uk, dhxretro.co.uk) and the U.S. (dhxkids.com, dhxjunior.com, dhxretro.com), and in multiple languages, including English, French, Japanese, Korean, Portuguese, Russian and Spanish. DHX Media digital channels content is available now for free sampling for two week free trials with a subscription price of $2.99 (U.S.)/month. Discounted yearly subscriptions are also available. DHX Media is a leading international creator, producer, distributor and licensor boasting the world’s most extensive independent library of globally recognized children’s entertainment.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61630-dhx-kids-dhx-junior-dhx-retro-paid-youtube-family-entertainment-channels
Clipping path or Silhouette/silo is the process of cutting out the original background of an image and inserting it into a new image or background. All the objects inside the path will be present after the clipping path is applied and others outside the path will be expunged from the output. Clipping path results in hard but fine edges.
www.shaangraphics.com provides overnight Image editing service such as silhouette, background removing, clipping path, Retouching, Color correction, masking services. Visit www.shaangraphics.com for more tutorials and free trials.
Clipping path or Silhouette/silo is the process of cutting out the original background of an image and inserting it into a new image or background. All the objects inside the path will be present after the clipping path is applied and others outside the path will be expunged from the output. Clipping path results in hard but fine edges.
www.shaangraphics.com provides overnight Image editing service such as silhouette, background removing, clipping path, Retouching, Color correction, masking services. Visit www.shaangraphics.com for more tutorials and free trials.
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world’s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57707-cord-blood-registry-stem-cell-trials-child-autism
Runner’s World, the authority on running information, will offer comprehensive, real-time coverage and continuous expert analysis of the Olympic Track and Field Trials, which run June 22-July 1 at historic Hayward Field in Eugene, OR.
Runner’s World’s coverage team in Eugene is anchored by longtime Runner’s World editor-at-large Amby Burfoot and veteran Running Times senior editor Scott Douglas, plus award-winning writer John Brant adding occasional columns and commentary, all of which are accessible at www.runnersworld.com/olympic-trials.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56842-runner-s-world-steps-up-july-issue-olympic-track-trials
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
According to Bing searches, 2011 was the year of musical superstars, continued celebrity fascination, concern for human tragedy and new royalty. From rising stars and weddings to intense trials and natural disasters, Bing has captured history through the searches that mark the year’s most important people, places and moments in time.
Based on the aggregation of billions of search queries conducted on Bing this year, here are the much-anticipated top 10 lists for the most searched people, news stories, sports stars, musicians, celebrity events, consumer electronics and TV shows. The complete report is available at http://www.BingTrends.com.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53369-2011-a-year-in-review-from-bing-top-searches
Best known as the chef and fisherman who ran a successful underground lobster roll business from his Brooklyn basement apartment, lifelong seafood lover Ben Sargent brings boundless knowledge, experience, and passion to his new primetime Cooking Channel series Hook, Line & Dinner. By bike, boat, car or surfboard, Ben Sargent embarks on the ultimate coastal road trip and uncovers the country’s regional seafood specialties and the local joints at which they are served, all while taking viewers on the awesome journey from sea to table. Premiering Tuesday, June 7th at 10:30 p.m. ET (7:30 p.m. PT), Ben strives to help viewers understand and appreciate seafood in a new way – from how it’s caught, shipped and prepared to the many trials and tribulations that can come along with this demanding and often unpredictable industry.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/foodnetwork/50341/
Medical researchers are making unprecedented progress into understanding why women suffer disproportionately from a number of diseases. Those insights are providing information to help develop medicines to attack diseases such as osteoporosis, multiple sclerosis, depression, rheumatoid arthritis and age-related macular degeneration, all of which affect more women than men.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/50270/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and haemodynamic monitoring, announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial. These data demonstrate that the study achieved its primary endpoint at one year, concluding that survival of patients treated with the Edwards SAPIEN transcatheter aortic valve was equivalent to those treated with surgical aortic valve replacement. The data were presented at the American College of Cardiology’s (ACC) 60th Annual Scientific Session & Expo in New Orleans, LA, USA.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/48895/
Now on the web, www.canceranswers123.com offers all the information about cancer in three clicks of a mouse. Medical information, clinical trials, blogs, webcasts, news in real time and video; all available at your reading leisure online at ca123.com or on a mobile app.
The latest in cancer information from the American Cancer Society is located right on the home page to help answer questions, and provide a patient support care network. Another use of the web portal is for medical practitioners who want to easily adapt an oncology specific site for use by their business or medical facility.
To view Multimedia News Release, go to http://www.multivu.com/players/English/46513-Cancer-Answers-123/
